Changes in prostaglandin levels in patients undergoing femtosecond laser-assisted cataract surgery

Journal of Refractive Surgery

Volumn 29, Issue 11, 2013, Pages 742-747

  Schultz, Tim ^a   Joachim, Stephanie C ^a   Kuehn, Mathias ^a   Dick, H Burkhard ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN; PROSTAGLANDIN E2;

AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMTOSECOND LASER; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PRIORITY JOURNAL; SURGICAL PATIENT; EXCIMER LASER; LENS IMPLANTATION; METABOLISM; MIOSIS; PROCEDURES; PROSPECTIVE STUDY; THERAPEUTIC USE;

AGED; AQUEOUS HUMOR; CATARACT EXTRACTION; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LASERS, EXCIMER; LENS IMPLANTATION, INTRAOCULAR; MALE; MIOSIS; PROSPECTIVE STUDIES; PROSTAGLANDINS;

EID: 84888607288     PISSN: 1081597X     EISSN: 19382391     Source Type: Journal    
DOI: 10.3928/1081597X-20131021-03     Document Type: Article

References (26)

1. Nagy Z, Takacs A, Filkorn T, Sarayba M. Initial clinical evaluation of an intraocular femtosecond laser in cataract surgery. J Refract Surg. 2009;25:1053-1060.
2. Friedman NJ, Palanker DV, Schuele G, et al. Femtosecond laser capsulotomy. J Cataract Refract Surg. 2011;37:1189-1198.
3. Conrad-Hengerer I, Hengerer FH, Schultz T, Dick HB. Effect of femtosecond laser fragmentation of the nucleus with different softening grid sizes on effective phaco time in cataract surgery. J Cataract Refract Surg. 2012;38:1888-1894.
4. Takács AI, Kovács I, Miháltz K, Filkorn T, Knorz MC, Nagy ZZ. Central corneal volume and endothelial cell count following femtosecond laser-assisted refractive cataract surgery compared to conventional phacoemulsification. J Refract Surg. 2012;28:387-391.
5. Ecsedy M, Miháltz K, Kovács I, Takács A, Filkorn T, Nagy ZZ. Effect of femtosecond laser cataract surgery on the macula. J Refract Surg. 2011;27:717-722.
6. Nagy ZZ, Kránitz K, Takacs AI, Miháltz K, Kovács I, Knorz MC. Comparison of intraocular lens decentration parameters after femtosecond and manual capsulotomies. J Refract Surg. 2011;27:564-569.
7. Miháltz K, Knorz MC, Alió JL, et al. Internal aberrations and optical quality after femtosecond laser anterior capsulotomy in cataract surgery. J Refract Surg. 2011;27:711-716.
8. Bali SJ, Hodge C, Lawless M, Roberts TV, Sutton G. Early experience with the femtosecond laser for cataract surgery. Ophthalmology. 2012;119:891-899.
9. Artzén D, Lundström M, Behndig A, Stenevi U, Lydahl E, Montan P. Capsule complication during cataract surgery: case-control study of preoperative and intraoperative risk factors: Swedish Capsule Rupture Study Group report 2. J Cataract Refract Surg. 2009;35:1688-1693.
10. Kuehl FA Jr, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science. 1980;210:978-984. (Pubitemid 11168243)
11. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120. (Pubitemid 28231490)
12. Cole DF, Unger WG. Prostaglandins as mediators for the responses of the eye to trauma. Exp Eye Res. 1973;17:357-368.
13. Maihöfner C, Schlötzer-Schrehardt U, Gühring H, et al. Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci. 2001;42:2616-2624. (Pubitemid 32954872)
14. Solomon KD, Turkalj JW, Whiteside SB, Stewart JA, Apple DJ. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol. 1997;115:1119-1122. (Pubitemid 27387946)
15. Keulen-de Vos HC, van Rij G, Renardel de Lavalette JC, Jansen JT. Effect of indomethacin in preventing surgically induced miosis. Br J Ophthalmol. 1983;67:94-96. (Pubitemid 13174343)
16. Roberts CW. Comparison of diclofenac sodium and flurbiprofen for inhibition of surgically induced miosis. J Cataract Refract Surg. 1996;22:1780-1787.
17. Gimbel HV. The effect of treatment with topical nonsteroidal anti-inflammatory drugs with and without intraoperative epinephrine on the maintenance of mydriasis during cataract surgery. Ophthalmology. 1989;96:585-588. (Pubitemid 19119459)
18. Bucci FA Jr, Waterbury LD. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing. Adv Ther. 2009;26:645-650.
19. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
20. Ambache N, Brummer HC. A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts. Br J Pharmacol Chemother. 1968;33:162-170.
21. Hall DW, Bonta IL. Prostaglandins and ocular inflammation. Doc Ophthalmol. 1977;44:421-434. (Pubitemid 8251509)
22. Lubatschowski H, Maatz G, Heisterkamp A, et al. Application of ultrashort laser pulses for intrastromal refractive surgery. Graefes Arch Clin Exp Ophthalmol. 2000;238:33-39. (Pubitemid 30160499)
23. Ueta M, Matsuoka T, Sotozono C, Kinoshita S. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells. Cornea. 2012;31:1294-1298.
24. Phillips AF, Hayashi S, Seitz B, Wee WR, McDonnell PJ. Effect of diclofenac, ketorolac, and fluorometholone on arachidonic acid metabolites following excimer laser corneal surgery. Arch Ophthalmol. 1996;114:1495-1498. (Pubitemid 26406264)
25. Matsuo T. Prostaglandins F2alpha and E2 in aqueous humor of patients with cataract surgery. J Ocul Pharmacol Ther. 2004;20:101-106. (Pubitemid 38456582)
26. Bucci FA Jr, Waterbury LD. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification. Adv Ther. 2011;28:1089- 1095.